Hematologic Malignancies Program

Hodgkin's Disease

What is Hodgkin's Disease? | Risk Factors | Symptoms | Stages and Treatments | About Clinical Trials | Greenebaum Cancer Center

At The University of Maryland Marlene and Stewart Greenebaum Cancer Center, patients with Hodgkin's disease are treated in the Center's Program for Hematologic Malignancies, which is staffed by experts in the research and treatment of cancers of the blood.

The Center's medical staff members take a fully integrated, multidisciplinary approach to cancer care so that every phase of treatment is coordinated for maximum effectiveness. Patients receive the most advanced and comprehensive treatment available anywhere in the world--in a compassionate and supportive setting.

For more information about Hodgkin's disease treatment at UMGCC, click here.

To make an appointment, call our toll-free number: 1-800-888-8823


This page was last updated on: March 3, 2008.